Companies Dominating the Neurothrombectomy Devices Landscape
- Penumbra Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- AngioDynamics, Inc.
- Edwards Lifesciences Corporation
- Medtronic
- Stryker Corporation
- Vesalio
- ACANDIS GmbH
- Boston Scientific Corporation
- Abbott Laboratories
- phenox GmbH
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Currently in 2025, the industry revenue of neurothrombectomy devices is assessed at USD 799.09 million.
The global neurothrombectomy devices market is projected to grow from USD 761.76 million in 2024 to USD 1.84 billion by 2037, exhibiting a CAGR of over 7% during the forecast period, between 2025 and 2037.
North America industry is expected to dominate majority revenue share of 36% by 2037, attributed to increasing occurrence of ischemic strokes in the region.
The major players in the market include Penumbra Inc., AngioDynamics, Inc., Edwards Lifesciences Corporation, Medtronic, Stryker Corporation, Vesalio, ACANDIS GmbH, Boston Scientific Corporation, Abbott Laboratories, phenox GmbH.
